385 results on '"Johann, Pascal"'
Search Results
2. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
3. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
4. SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability.
5. Refractory and relapsed paediatric ACC in the MET studies – A challenging situation necessitating novel diagnostic and therapeutic concepts
6. Oligo- and polymetastatic paediatric adrenocortical carcinoma - distinct conditions necessitating different treatment approaches?
7. Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study
8. ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
9. DNA methylation-based classification of sinonasal tumors
10. Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors
11. Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
12. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
13. “Adult rhabdoid tumors—a riddle inside an enigma?”
14. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
15. Cui Bono? Identifying Patient Groups That May Benefit From Granulocyte Transfusions in Pediatric Hematology and Oncology
16. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
17. Sarcoma classification by DNA methylation profiling
18. Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury
19. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
20. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
21. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
22. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.
23. Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
24. Rhabdoid tumors in patients conceived following ART: is there an association?
25. §§ 111b-111q
26. Systematic identification of suspected anthelmintic benzimidazole metabolites using LC–MS/MS
27. Embryonal tumor with multilayered rosettes located in the brainstem: Promising results after multimodal treatment including interstitial brachytherapy.
28. Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1
29. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors
30. Supplementary Table from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
31. Data from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
32. Supplementary Figure from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
33. Vorwort
34. Möglichkeiten und Grenzen des neuen Vermögensabschöpfungsrechts
35. Data from A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
36. Supplementary Appendix from A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
37. Supplementary Figures from Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
38. Supplementary Tables from A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
39. Epigenetic Modification of Mesenchymal Stromal Cells Derived from Bone Marrow and Embryonal Tumors to Facilitate Immunotherapeutic Approaches in Pediatric Malignancies
40. RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression
41. Outcome for Pediatric Adreno-Cortical Tumors Is Best Predicted by the COG Stage and Five-Item Microscopic Score—Report from the German MET Studies
42. Renal Medullary Carcinomas Harbor a Distinct Methylation Phenotype and Display Aberrant Methylation of Genes Related to Early Nephrogenesis
43. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors
44. Transcriptional immunogenomic analysis reveals distinct immunological clusters in pediatric nervous system tumours
45. Active medulloblastoma enhancers reveal subgroup-specific cellular origins
46. NFB-13. Rhabdoid Tumor Predisposition Syndrome (RTPS) – Finding Evidence by systematic Analyses
47. ATRT-04. Clinical and (epi)genetic characterisation of patients with atypical teratoid/rhabdoid tumor (ATRT) and extracranial malignant rhabdoid tumor conceived following assisted reproduction technologies (ART)
48. ATRT-14. Malignant rhabdoid tumors of cranial nerves – ATRT or extracranial rhabdoid tumor?
49. ATRT-08. SMARCB1- and SMARCA4-deficient malignant brain tumors with complex copy number alterations andTP53 mutations may represent the first clinical manifestation of Li-Fraumeni syndrome
50. IMMU-04. Transcriptional analysis reveals distinct microenvironmental subgroups across pediatric nervous system tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.